Tag: Quipt Home Medical
Quipt makes play for diabetes
May 17, 2024Theresa Flaherty, Managing Editor
CINCINNATI – Quipt Home Medical has dipped its toe into the diabetes market, which company execs say represents a “promising avenue” for growth.
The company started testing the market in fiscal 2023, offering CGMs and supplies in certain markets, CEO Greg Crawford said on a call to discuss second fiscal quarter 2024 earnings.
“The early signs have looked pretty good for us, so now we're in the process of expanding that around the rest of the company,”...
Quipt reports Q2 increase, announces plans to add diabetes
May 16, 2024HME News Staff
CINCINNATI – Quipt Home Medical reported revenue of $64 million for its second fiscal quarter 2024, a 10% increase year over year.
Revenues for the six months ended March 31, 2024, were $129.3 million, a 31% increase year over year.
“We are very proud of the resilience of our business and our ability to maintain our strong margin profile amid certain industry-related challenges experienced during fiscal Q2,” said Greg Crawford, CEO and chairman. “We have...
Quipt Home Medical implements capital allocation option
May 6, 2024HME News Staff
CINCINNATI – Quipt Home Medical has announced the Toronto Stock Exchange has accepted its notice of intention to implement a normal course issuer bid (NCIB). Under the NCIB, the company may purchase for cancellation up to 3,626,845 common shares from time to time in accordance with applicable securities laws, representing approximately 10% of the company’s public float (as defined by the TSX). “We are pleased to announce this NCIB as an additional capital allocation option...
Quipt addresses investigation, commits to e-prescribing
February 23, 2024Theresa Flaherty, Managing Editor
CINCINNATI – Quipt Home Medical’s strong fiscal first quarter was tempered by news of a recently-announced investigation into certain claims, during a recent earnings call.
Quipt has disclosed that it has received a civil investigative demand from the U.S. Attorney’s Office for the Northern District of Georgia pursuant to the False Claims Act regarding an investigation concerning whether the company may have caused the submission of false claims to government health...
In brief: Quipt’s ‘robust’ quarter, Cardinal’s raised guidance, Paragon’s 30th anniversary
February 16, 2024HME News Staff
CINCINNATI – Quipt Home Medical reported revenue of $65.4 million for the first quarter of fiscal 2024, a 60% increase compared to the same period last year.
Adjusted EBITDA was $15.3 million (23.5% of revenue) vs. $9.0 million (22% of revenue), a 71% increase; and net income (loss) was $(0.6) million vs. $0.3 million.
“We continued experiencing robust demand trends in the first quarter across our diverse product offering and are very pleased with the continued record...
Quipt reports ‘robust’ financial results
February 15, 2024HME News Staff
CINCINNATI – Quipt Home Medical reported revenue of $65.4 million for the first quarter of fiscal 2024, a 60% increase compared to the same period last year.
Adjusted EBITDA was $15.3 million (23.5% of revenue) vs. $9.0 million (22% of revenue), a 71% increase; and net income (loss) was $(0.6) million vs. $0.3 million.
“We continued experiencing robust demand trends in the first quarter across our diverse product offering and are very pleased with the continued record...
In brief: Older adults & tech adoption, Quipt’s new capital
January 3, 2024HME News Staff
WASHINGTON – A new AARP survey finds that older Americans are just as likely to own a smartphone, tablet or other device.
Nearly nine out of 10 Americans – 89% of those 50-plus and 90% of those 18-49 – own a smart phone, according to “2024 Tech Trends and Adults 50+.”
Other findings:
Only 13% of adults 50-plus are currently taking advantage of technology to manage their health, despite 69% having one or more chronic or serious conditions....
Quipt accesses new capital
January 2, 2024HME News Staff
CINCINNATI – Quipt Home Medical has filed a preliminary short form base shelf prospectus with the securities commission in each of the provinces and territories of Canada, as well as a corresponding registration statement on Form F-10 with the U.S. Securities and Exchange Commission under the U.S./Canada Multijurisdictional Disclosure System. The shelf prospectus and registration statement allow the company to offer up to C$300,000,000 of common shares/preferred shares/debt securities/warrants...
Quipt Home Medical looks to ‘favorable’ 2024
December 21, 2023Theresa Flaherty, Managing Editor
CINCINNATI – Quipt Home Medical sees no signs of “slowing down” as it continues to drive organic growth rates of 8% to 10% annually, company execs say.
Quipt expects that growth to continue steadily into 2024, said CEO Greg Crawford on a recent call to discuss the company’s fourth quarter and fiscal year 2023 earnings.
“Due to our focus on growing the continuum of care, cross-selling product categories, taking advantage of the benefits of normalized...
Quipt looks to ‘favorable’ 2024
December 21, 2023Theresa Flaherty, Managing Editor
CINCINNATI – Quipt Home Medical sees no signs of “slowing down” as it continues to drive organic growth rates of 8% to 10% annually, company execs say.
Quipt expects that growth to continue steadily into 2024, said CEO Greg Crawford on a recent call to discuss the company’s fourth quarter and fiscal year 2023 earnings.
“Due to our focus on growing the continuum of care, cross-selling product categories, taking advantage of the benefits of normalized...